Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)
Mazen Hanna, Thibaud Damy, Martha Grogan, Michelle Stewart, Balarama Gundapaneni, Terrell A. Patterson, Jeffrey H. Schwartz, Marla B. Sultan, Mathew S. Maurer
Topics & Concepts
MedicineTransthyretinPlaceboInternal medicineQuality of life (healthcare)Confidence intervalClinical trialRandomized controlled trialCardiomyopathyPhysical therapyHeart failurePathologyAlternative medicineNursingAmyloidosis: Diagnosis, Treatment, OutcomesEosinophilic Disorders and SyndromesPeptidase Inhibition and Analysis